Skip to main content
OpenTrials

Clinical trial condition

Osteosarcoma

Explore clinical trials studying Osteosarcoma. Study availability and eligibility vary by location and protocol.

341 public trials 85 recruiting studies
Refine in advanced search Browse all conditions

Osteosarcoma trial results

Completed

Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma (OAIE)

NCT05277480

Conditions
Drug, Effect of Drug, Neoplasms, +7 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University Nanjing, Jiangsu, China
  • Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Completed

A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma

NCT04154189

Conditions
Disease Attributes, Neoplasms, Neoplasms by Histologic Type, +8 more
Locations
  • Children's of Alabama Birmingham, Alabama, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Benioff Children's Hospitals San Francisco, California, United States
View all 84 locations
View Trial Details
Completed

Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors

NCT03320330

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +8 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
View all 24 locations
View Trial Details
Completed

A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors

NCT05093322

Conditions
Ewing Sarcoma, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Childrens Hospital Orange County Orange, California, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
View Trial Details
Completed

ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma

NCT01459484

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +4 more
Locations
  • I.R.C.C. - Unit of Medical Oncology Candiolo, Torino, Italy
  • Presidio Sanitario Gradenigo Torino, TO, Italy
  • IRCCS Istituto ortopedico Rizzoli Bologna, Italy
  • A.O. Universitaria Meyer Florence, Italy
View Trial Details

Related conditions